Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05374408 · ClinicalTrials.gov registry record
Using Mobile Technology to Address the Trauma Mental Health Treatment Gap
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 29
- Enrollment target
NCT05374408: Completed study, sponsored by University of Nebraska.
NCT05374408 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05374408 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
BounceBack Now (BBN) is a self-help, trauma-focused mental health mobile application (app) with automated assessment with treatment guidance and in-app evidence-based treatment support for depression, post-traumatic stress disorder (PTSD), sleep difficulties, and anxiety. BBN contains many of the necessary components to promote self-management of these conditions. Investigators will evaluate the app's feasibility and acceptability among under served participants (e.g., African Americans and participants with lower socioeconomic status) with trauma histories in an integrated primary care (IPC) setting. There are two specific aims: 1) to develop educational materials for patients and behavioral health providers for BBN in IPC, and 2) to conduct a pilot trial of BBN for participants with trauma histories in an IPC setting. For Aim 1, focus groups with behavioral health providers and participants will be conducted to obtain feedback about BBN and training materials. For Aim 2, a feasibility study with 15 participants will be conducted to identify and address any procedural issues and to refine the protocol before conducting the full-scale study.
Primary Outcome
Educational Materials that have been developed related to using a trauma related mobile app will be evaluated by focus groups comprised of Patients and BHPs. The participants will be asked to use a think aloud approach using semi-structured interviews in order to determine the acceptability, usability and feasibility of the materials using questions developed to evaluate these items assessed during the focus group.
Interventions
- BEHAVIORAL Aim 2: BounceBack Now (BBN) for Trauma Informed Care Deployment
- BEHAVIORAL Aim 1 Participant Focus Groups
- BEHAVIORAL Aim 1 BHP Focus Groups
- BEHAVIORAL Aim 2: BHP, Provider, Staff and Admin Focus Groups
- BEHAVIORAL Aim 2 : Participant Focus Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2022-08-03 |
| Est. Completion | 2024-03-22 |
What the finished NCT05374408 record still lists
NCT05374408 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which Aim 2: BounceBack Now (BBN) for Trauma Informed Care Deployment is the first listed.
NCT05374408 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05374408 about?
NCT05374408 is a clinical study titled "Using Mobile Technology to Address the Trauma Mental Health Treatment Gap". BounceBack Now (BBN) is a self-help, trauma-focused mental health mobile application (app) with automated assessment with treatment guidance and in-app evidence-based treatment support for depression, post-traumatic stress disorder (PTSD), sleep difficulties, and anxiety. BBN contains many of the ne...
What is the current status of trial NCT05374408?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2022-08-03. Estimated completion is 2024-03-22.
What interventions are being tested in trial NCT05374408?
The interventions under investigation include: Aim 2: BounceBack Now (BBN) for Trauma Informed Care Deployment (BEHAVIORAL), Aim 1 Participant Focus Groups (BEHAVIORAL), Aim 1 BHP Focus Groups (BEHAVIORAL), Aim 2: BHP, Provider, Staff and Admin Focus Groups (BEHAVIORAL), Aim 2 : Participant Focus Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05374408?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI